Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home IV vs Oral Antibiotics for Perforated Appendicitis in Children
NCT02724410Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of amoxicillin + clavulanate in perforated appendicitis (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Number of Participants With Postoperative Abscess at 30 days, Number of Participants With Wound Infections at 30 days and 2 more. Started Jan 2011; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
perforated appendicitis
Beyond the preview
Go deeper on NCT02724410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724410.